Search

The paper describes quantitative and qualitative dimensions of nanomedicine research studies in India. The study is based on research publications data in nanomedicine research (1491 publications) as covered in Scopus data base for the period 2002-20. The study finds that nanomedicine research in India registered a high 73.7% growth with an average of 22.93 citations per paper. The nano-oncology subfield accounted for the highest share (48.49% share) in the national output, followed by seven other nanomedicine subfields. Jamia Hamdard University, Delhi, Panjab University, Chandigarh and Banaras Hindu University, Varanasi lead as the most productive organizations in the country. The paper also lists the most productive authors in nanomedicine research. The most productive research journals that reported nanomedicine research in India include Nanomedicine, International Journal of Nanomedicine and Current Pharmaceutical Design. In addition, International Journal of Pharmaceutics, International Journal of Nanomedicine and Drug Delivery Today topped in the list of most cited research journals. [ABSTRACT FROM AUTHOR]

Nanomedicine is a novel and challenging field in terms of its governance. It is gradually emerging that the existing regulatory regimes may not be able to accommodate the requirements of nanomedicine without amendments or supportive measures. Further, its multidisciplinary essence poses challenges and indicates a need for an adaptive regulatory framework for governance as well as promotion of innovation system. The best strategy to govern nanomedicine remains highly debatable across the globe. Although, major challenges posed by nanomedicine are universal, some of them are specific to each country, hence, making a jurisdiction-based framework essential to address unique needs of a nation. In India, a clear framework for the regulation of nanomedicine is lacking, as this governance gap has been realized through various studies. Keeping this in view, the authors propose a multi-level national governance system for regulation of nanomedicine in India based on four principles. The hierarchical governance model proposed involves regulatory space, policy regime, sites of governance and lifecycle of nanomedicine. The proposed system is inclusive of its various stakeholders. The system can play a significant role in sustainable growth of nanomedicine in India. [ABSTRACT FROM AUTHOR]